Pacific Biosciences Of California (PACB) Operating Leases (2019 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Operating Leases of $59.0 million for Q1 2026, up 16.89% year-over-year from $50.5 million in Q1 2025, and up 4.26% quarter-over-quarter from $56.6 million in Q4 2025.
Pacific Biosciences Of California (PACB) Operating Leases (2019 - 2026) Analysis & Trends
Pacific Biosciences Of California's Operating Leases history runs 8 years deep, the most recent figure standing at $59.0 million for Q1 2026.
- In Q1 2026, Operating Leases rose 16.89% year-over-year to $59.0 million; the TTM figure through Mar 2026 stood at $59.0 million (up 16.89% YoY), while the FY2025 annual figure was $56.6 million, up 279.46% from the prior year.
- Operating Leases for Q1 2026 stood at $59.0 million, up from $56.6 million in the prior quarter.
- The five-year high for Operating Leases was $59.0 million in Q1 2026, with the low at $14.9 million in Q4 2024.
- The 5-year median for Operating Leases is $40.0 million (2022), against an average of $38.7 million.
- The sharpest annual moves came in 2024 and 2025: Operating Leases tumbled 52.81% in 2024, then surged 279.46% in 2025.
- Pacific Biosciences Of California's Operating Leases stood at $41.1 million in 2022, then dropped by 23.04% to $31.6 million in 2023, then sank by 52.81% to $14.9 million in 2024, then soared by 279.46% to $56.6 million in 2025, then rose by 4.26% to $59.0 million in 2026.
- Business Quant data shows PACB's Operating Leases at $59.0 million in Q1 2026, $56.6 million in Q4 2025, and $54.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 381.79 Mn | 144.92 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 60.42 Mn |
| Mar 31, 2026 | 59.00 Mn |
| Dec 31, 2025 | 56.59 Mn |
| Sep 30, 2025 | 54.30 Mn |
| Mar 31, 2025 | 50.48 Mn |
| Dec 31, 2024 | 14.91 Mn |
| Sep 30, 2024 | 16.93 Mn |
| Jun 30, 2024 | 19.62 Mn |
| Mar 31, 2024 | 29.05 Mn |
| Dec 31, 2023 | 31.61 Mn |
| Sep 30, 2023 | 34.10 Mn |
| Jun 30, 2023 | 36.60 Mn |
| Mar 31, 2023 | 38.97 Mn |
| Dec 31, 2022 | 41.07 Mn |
| Sep 30, 2022 | 43.16 Mn |
| Jun 30, 2022 | 45.50 Mn |
| Mar 31, 2022 | 47.74 Mn |
| Dec 31, 2021 | 49.97 Mn |
| Sep 20, 2021 | 18.10 Mn |
| Jun 30, 2021 | 35.43 Mn |